Syndax closes $172.5M public offering; shares outstanding ~68.1M

Syndax Pharmaceuticals Inc

Gross proceeds of $172.5M from 7,840,909 shares at $22.00 per share.
Underwriters exercised full overallotment for 1,022,727 additional shares.
Goldman Sachs, J.P. Morgan and Cowen acted as joint book-running managers.
Shares outstanding after offering stand at 68,100,918 as of December 14, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.